These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 32839657)

  • 1. Pharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolism.
    Röshammar D; Huang F; Albisetti M; Bomgaars L; Chalmers E; Luciani M; Halton J; Mitchell LG; Bergstrand M; Ibrahim MMA; Joseph D; Tartakovsky I; Gropper S; Brueckmann M; Brandão LR
    J Thromb Haemost; 2021 May; 19(5):1259-1270. PubMed ID: 33636042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics of Phosphocreatine and Its Metabolite Creatine in Children With Myocarditis.
    He H; Zhang M; Zhao LB; Sun N; Zhang Y; Yuan Y; Wang XL
    Front Pharmacol; 2020; 11():574141. PubMed ID: 33658923
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population.
    Carreño FO; Gerhart JG; Helfer VE; Sinha J; Kumar KR; Kirkpatrick C; Hornik CP; Gonzalez D;
    Clin Pharmacokinet; 2024 Jul; ():. PubMed ID: 38955947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old.
    Khalil F; Choi SL; Watson E; Tzschentke TM; Lefeber C; Eerdekens M; Freijer J
    J Pain Res; 2020; 13():3107-3123. PubMed ID: 33262645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tofacitinib pharmacokinetics in children and adolescents with juvenile idiopathic arthritis.
    Chang C; Vong C; Wang X; Hazra A; Diehl A; Nicholas T; Mukherjee A
    CPT Pharmacometrics Syst Pharmacol; 2024 Apr; 13(4):599-611. PubMed ID: 38298058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and Proposed Dosing of Levetiracetam in Children With Obesity.
    Zimmerman KO; Wu H; Maharaj A; Turner A; Chen JY; Hornik CD; Arnold S; Muller W; Al-Uzri A; Meyer M; Shiloh-Malawsky Y; Taravath S; Lakhotia A; Joshi C; Jackman J; Hornik CP
    J Pediatr Pharmacol Ther; 2023; 28(8):693-703. PubMed ID: 38094673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children.
    Hornik CP; Gonzalez D; van den Anker J; Atz AM; Yogev R; Poindexter BB; Ng KC; Delmore P; Harper BL; Melloni C; Lewandowski A; Gelber C; Cohen-Wolkowiez M; Lee JH;
    J Clin Pharmacol; 2018 Aug; 58(8):1092-1104. PubMed ID: 29677389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics, enzyme occupancy, and pharmacodynamic modeling of soticlestat in patients with developmental and epileptic encephalopathies.
    Yin W; Facius A; Asgharnejad M; Lahu G; Vakilynejad M
    Clin Transl Sci; 2024 Mar; 17(3):e13722. PubMed ID: 38445548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria.
    Yoon S; Jin BH; Kim CO; Park K; Park MS; Chae D
    Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetics of Doxycycline in Children.
    Thompson EJ; Wu H; Melloni C; Balevic S; Sullivan JE; Laughon M; Clark KM; Kalra R; Mendley S; Payne EH; Erinjeri J; Gelber CE; Harper B; Cohen-Wolkowiez M; Hornik CP;
    Antimicrob Agents Chemother; 2019 Sep; 63(12):. PubMed ID: 31548185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacological overview of aprepitant for the prevention of postoperative nausea and vomiting.
    Padilla A; Habib AS
    Expert Rev Clin Pharmacol; 2023; 16(6):491-505. PubMed ID: 37128935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Emend on Perioperative Bariatric Surgery Antiemetic Utilization, Patient Satisfaction, and Costs.
    Aghazarian GS; Lind R; Motola D; Perry M; Singletary N; Lastrapes L; Ghanem M; Jawad MA; Teixeira AF
    Surg Laparosc Endosc Percutan Tech; 2023 Jun; 33(3):265-269. PubMed ID: 36821697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overestimation of the effect of (fos)aprepitant on intravenous dexamethasone pharmacokinetics requires adaptation of the guidelines for children with chemotherapy-induced nausea and vomiting.
    Nijstad AL; de Vos-Kerkhof E; Enters-Weijnen CF; van de Wetering MD; Tissing WJE; Tibben MM; Rosing H; Lalmohamed A; Huitema ADR; Zwaan CM
    Support Care Cancer; 2022 Dec; 30(12):9991-9999. PubMed ID: 36287279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update on PONV-What is new in prophylaxis and treatment of postoperative nausea and vomiting? : Summary of recent consensus recommendations and Cochrane reviews on prophylaxis and treatment of postoperative nausea and vomiting].
    Kienbaum P; Schaefer MS; Weibel S; Schlesinger T; Meybohm P; Eberhart LH; Kranke P
    Anaesthesist; 2022 Feb; 71(2):123-128. PubMed ID: 34596699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling and Simulation Analysis of Aprepitant Pharmacokinetics in Pediatric Patients With Postoperative or Chemotherapy-Induced Nausea and Vomiting.
    Chain A; Wrishko R; Vasilinin G; Mouksassi S
    J Pediatr Pharmacol Ther; 2020; 25(6):528-539. PubMed ID: 32839657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics/pharmacodynamics, safety, and tolerability of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric cancer patients.
    Mora J; Valero M; DiCristina C; Jin M; Chain A; Bickham K
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27690. PubMed ID: 30900392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple extemporaneous oral suspension of aprepitant yields sufficient pharmacokinetic exposure in children.
    Nijstad AL; de Vos-Kerkhof E; Enters-Weijnen CF; van de Wetering MD; Tissing WJE; Hanff LM; Lange R; Tibben MM; Rosing H; Lalmohamed A; Zwaan CM; Huitema ADR
    J Oncol Pharm Pract; 2023 Jun; 29(4):899-904. PubMed ID: 35377726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of aprepitant for the prevention of postoperative nausea and vomiting in pediatric subjects.
    Salman FT; DiCristina C; Chain A; Afzal AS
    J Pediatr Surg; 2019 Jul; 54(7):1384-1390. PubMed ID: 30381138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1733-42. PubMed ID: 18983233
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.